Physician profile
Min Cai
NPI 1003813676
$3,881.46
in general payments reported to CMS, 2019-2025
21 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $301 · 2021: $85.41 · 2022: $591 · 2023: $593 · 2024: $581 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $965.76 | 2019-2025 | Linzess, Viberzi, Creon |
| Novo Nordisk INC | $481.10 | 2019-2025 | Ozempic, Rybelsus |
| Gilead Sciences, INC. | $411.25 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $406.26 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $351.50 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $340.38 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $159.91 | 2019-2024 | Gardasil, Gardasil 9 |
| Lilly USA, LLC | $153.15 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $119.03 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $103.36 | 2019 | |
| Allergan, INC. | $98.30 | 2019 | |
| Pfizer INC. | $63.98 | 2019-2020 | |
| Glaxosmithkline, LLC. | $55.83 | 2024-2025 | Trelegy Ellipta |
| Ironwood Pharmaceuticals, INC | $42.59 | 2024 | |
| Genentech USA, INC. | $37.95 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $19.03 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.03 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2020 | |
| Phadia US INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Cai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.